Vávra, J.; Sergunin, A.; Farná, A.; Ovad, T.; Shimizu, T.; MartÃnková, M.
Is ATP the Only Nucleoside Triphosphate among ATP, CTP, GTP, and UTP to Have a Role in Kinase Catalysis of Heme-Regulated Inhibitor toward eIF2α during Lung Cancer Development? Catalysts 2023, 13, 281.
https://doi.org/10.3390/catal13020281
AMA Style
Vávra J, Sergunin A, Farná A, Ovad T, Shimizu T, MartÃnková M.
Is ATP the Only Nucleoside Triphosphate among ATP, CTP, GTP, and UTP to Have a Role in Kinase Catalysis of Heme-Regulated Inhibitor toward eIF2α during Lung Cancer Development? Catalysts. 2023; 13(2):281.
https://doi.org/10.3390/catal13020281
Chicago/Turabian Style
Vávra, Jakub, Artur Sergunin, AlžbÄ›ta Farná, Tomáš Ovad, Toru Shimizu, and Markéta MartÃnková.
2023. "Is ATP the Only Nucleoside Triphosphate among ATP, CTP, GTP, and UTP to Have a Role in Kinase Catalysis of Heme-Regulated Inhibitor toward eIF2α during Lung Cancer Development?" Catalysts 13, no. 2: 281.
https://doi.org/10.3390/catal13020281
APA Style
Vávra, J., Sergunin, A., Farná, A., Ovad, T., Shimizu, T., & MartÃnková, M.
(2023). Is ATP the Only Nucleoside Triphosphate among ATP, CTP, GTP, and UTP to Have a Role in Kinase Catalysis of Heme-Regulated Inhibitor toward eIF2α during Lung Cancer Development? Catalysts, 13(2), 281.
https://doi.org/10.3390/catal13020281